[1]
“ Inflammation as a Modifiable Driver of Ischemic Heart Disease: Mechanisms, Clinical Risks, and Evolving Therapeutic Options”, JOC, vol. 24, no. 10s, pp. 488–501, Dec. 2025, doi: 10.64149/J.Carcinog.24.10s.488-501.